Chinese Journal of Tissue Engineering Research ›› 2017, Vol. 21 ›› Issue (25): 3937-3942.doi: 10.3969/j.issn.2095-4344.2017.25.001

    Next Articles

Effects of fibroblast growth factor on proliferation and differentiation of serially passaged bone marrow mesenchymal stem cells

Song Ming-yu1, Yang Yong2, Wu Hua2, Wang Rong3   

  1. 1Department of Obstetrics and Gynecology, 2Department of Orthopedics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei Province, China; 3Department of Gastroenterology, General Hospital of the Yangtse River Shipping, Wuhan 430015, Hubei Province, China
  • Revised:2017-03-26 Online:2017-09-08 Published:2017-10-09
  • Contact: Wang Rong, Master, Attending physician, Department of Gastroenterology, General Hospital of the Yangtse River Shipping, Wuhan 430015, Hubei Province, China
  • About author:Song Ming-yu, M.D., Attending physician, Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei Province, China
  • Supported by:

    the National Natural Science Foundation of China for the Youth, No. 81301552, 51707075

Abstract:

BACKGROUND: The source of bone marrow mesenchymal stem cells (BMSCs) is limited, and the cellular morphology, proliferation and multi-directional differentiation capacities can vary during serial passages in BMSCs in vitro.
OBJECTIVE: To study the effects of fibroblast growth factor (FGF) on cellular morphology, proliferation and differentiation of serially passaged BMSCs.
METHODS: (1) BMSCs were isolated from Sprague-Dawley rats and cultured. These cells were passaged six times in vitro, and the cellular morphology was observed and photographed. (2) BMSCs at passage 6 were seeded into 96-well plates and randomly divided into control group and FGF treatment group. The proliferation of cells in both groups was detected with cell counting kit-8 kit at days 1, 2, 3, 4, 5, 6, 7 after culture. (3) BMSCs at passage 6 were seeded into 6-well plates and randomly divided into control group and FGF treatment group. After 7 days treatment with growth medium or growth medium containing FGF, the cellular morphology was observed and photographed. And then the cells of both groups were treated with osteogenic induction medium, adipogenic induction medium and chondrogenic induction medium for the next 7 days. The osteogenic, adipogenic and chondrogenic related genes (RUNX2, ALP, OCN; PPARγ2, AP2, ADIPOQ; SOX9, collagen II, aggrecan) were detected with real-time PCR. The protein expressions of RUNX2, PPARγ2, SOX9 were detected with western blot assay. (4) BMSCs at passage 6 were seeded into 6-well plates and randomly divided into control group and FGF treatment group. After 7 days treatment with growth medium or growth medium containing FGF, the cells were cultured with osteogenic induction medium, adipogenic induction medium and chondrogenic induction medium for the next 14 days. Then, alizarin red S staining, oil red O staining and alcian blue staining were performed.
RESULTS AND CONCLUSION: (1) After in vitro passage for six times, the cellular morphology changed obviously, and FGF treatment recovered the characteristics of primary cells. (2) Compared with the control group, the cell proliferation in the FGF treatment group was significantly increased (P < 0.05). (3) Compared with the control group, the expression of osteogenic, adipogenic and chondrogenic related genes (RUNX2, ALP, OCN; PPARγ2, AP2, ADIPOQ; SOX9, collagen II, aggrecan) was increased significantly in the FGF treatment group (P < 0.05). The protein expressions of RUNX2, PPARγ2, SOX9 were also higher in the FGF treatment group than the control group (P < 0.05). (4) Compared with the control group, the number of extracellular calcium nodules, the number of intracellular lipid droplets, and the expression of acid acidic mucopolysaccharide were significantly increased after FGF pretreatment. To conclude, FGF pretreatment can preserve the stemness of BMSCs serially passaged in vitro.

 

Key words: Bone Marrow, Mesenchymal Stem Cells, Fibroblast Growth Factors, Cell Proliferation, Cell Differentiation, Tissue Engineering

CLC Number: